These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Glaucoma, miotic therapy and cataract. VI. Experimental studies on the guinea pig eye. Axelsson U Acta Ophthalmol (Copenh); 1969; 47(4):1057-67. PubMed ID: 5394839 [No Abstract] [Full Text] [Related]
4. [Experimental research on the cataractogenic action of some miotic collyria]. Boles Carenini B; Orzalesi N Boll Ocul; 1966 Dec; 45(12):847-61. PubMed ID: 5999515 [No Abstract] [Full Text] [Related]
5. Glaucoma, miotic therapy and cataract. V. Studies on the lens in glaucoma eyes after discontinuance of echothiophate (phospholine iodide) therapy. Axelsson U Acta Ophthalmol (Copenh); 1969; 47(4):1049-56. PubMed ID: 5394838 [No Abstract] [Full Text] [Related]
6. Lens opacities in glaucoma patients on phospholine iodide therapy. De Roetth A Trans Ophthalmol Soc U K (1962); 1966; 86():89-100. PubMed ID: 5226620 [No Abstract] [Full Text] [Related]
7. The influence of miotics on the lens. Firth JM; Vucicevic ZM; Tsou KC Ann Ophthalmol; 1973 Jun; 5(6):685-90. PubMed ID: 4718633 [No Abstract] [Full Text] [Related]
8. Streptozotocin-induced cataracts and miotics. White JH; Cinotti AA Ann Ophthalmol; 1971 Jun; 3(6):638-40. PubMed ID: 4275610 [No Abstract] [Full Text] [Related]
9. The effects of phospholine-iodide on the energy metabolism of the lens. Tarkkanen A; Härkönen M Ophthalmologica; 1969; 158 Suppl():455-61. PubMed ID: 4243274 [No Abstract] [Full Text] [Related]
10. Glaucoma, miotic therapy and cataract. 3. Visual loss due to lens changes in glaucoma eyes treated with paraoxon (Mintacol), echothiophate (phospholine iodide) or pilocarpine. Axelsson U Acta Ophthalmol (Copenh); 1968; 46(4):831-45. PubMed ID: 5755701 [No Abstract] [Full Text] [Related]
12. [Studies of the behavior of the enzymes of the "shunt" of hexose monophosphate in presence of miotic substances]. Calabria GA; Castellazzo R Boll Soc Ital Biol Sper; 1967 Sep; 43(18):1190-4. PubMed ID: 4383717 [No Abstract] [Full Text] [Related]
13. [Studies on the enucleated lens. 3. Cation content in naphthalene cataractous lens]. Ikemoto F; Iwata S; Narita F Yakugaku Zasshi; 1969 Jun; 89(6):745-9. PubMed ID: 5817223 [No Abstract] [Full Text] [Related]
15. Influence of various miotics on cataract formation. Abraham SV; Teller JJ Br J Ophthalmol; 1969 Dec; 53(12):833-8. PubMed ID: 5386373 [No Abstract] [Full Text] [Related]
16. [Experimental studies of the action of a cholinesterase inhibitor (phospholine iodide) on the permeability of the crystalline lens to cations]. Secchi AG; Levi Minzi S; Segato T; Steindler P Ann Ottalmol Clin Ocul; 1971 Jan; 97(1):9-14. PubMed ID: 5122648 [No Abstract] [Full Text] [Related]
17. The frequency of cataract after miotic therapy. Axelsson U; Holmberg A Acta Ophthalmol (Copenh); 1966; 44(3):421-9. PubMed ID: 5953238 [No Abstract] [Full Text] [Related]
18. [Studies on the electrolytes and water in the various experimental cataracts. I. Change in electrolytes and water content of the naphthalene cataract]. Oshima T Nippon Ganka Gakkai Zasshi; 1968 Sep; 72(9):1753-8. PubMed ID: 5751579 [No Abstract] [Full Text] [Related]
19. Effect of echothiophate iodide on the lens. Morton WR; Drance SM; Fairclough M Am J Ophthalmol; 1969 Dec; 68(6):1003-10. PubMed ID: 5362877 [No Abstract] [Full Text] [Related]
20. A biochemical evaluation of a cataract induced in a high-glucose medium. Chylack LT; Kinoshita JH Invest Ophthalmol; 1969 Aug; 8(4):401-12. PubMed ID: 5796271 [No Abstract] [Full Text] [Related] [Next] [New Search]